1. Jiang DC, Bai XR, Zhang QX, Lu W, Wang YQ, Li L, Mueller M. Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling. Eur J Clin Pharmacol. 2009;65(12):1187-93.(SCI收录, IF 2.497)2. Jiang DC, Wang L, Wang YQ, Li L, Lu W, Bai XR. Population Pharmacokinetics of Valproate in Children with Epilepsy in Chinese. Acta Pharmacol Sin, 2007，28 (10)： 1677-84(SCI收录, IF 1.677)3. Jiang DC, WANG L. Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy. Acta Pharmacol Sin，2004，25(12)：1576-83(SCI收录, IF 1.125)4. Chu YQ, Cai LJ, Jiang DC, Jia D, Yan SY, Wang YQ. Allergic shock and death associated with protamine administration in a diabetic patient. Clin Ther，2010,32(10):1729-1732(SCI收录, IF 3.25)5. Jiang DC, Wang YQ，Yan SY, Lin XL, Guo H, Wang YW. A comparison of Chinese hospital pharmacy and the Basel statements. International Pharmacy Journal, 2010, 26(2): 42-44(SCI收录, IF 1.05)
